Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lane

Showing results (621-630 of 703) with videos related to

Pageof 71
Sort By:
The Journal of Infectious Diseases|November 1, 1994
Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasmaR L Dewar, H C Highbarger, M D Sarmiento, et al.
The Journal of Infectious Diseases|March 14, 1998
Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoireJ C Gea-Banacloche, E E Weiskopf, C Hallahan, et al.
Science (New York, N.Y.)|September 7, 2019
Evaluation of an antibody to α<sub>4</sub>β<sub>7</sub> in the control of SIVmac239-<i>nef-stop</i> infectionM Di Mascio, J D Lifson, S Srinivasula, et al.
AIDS (London, England)|September 14, 2000
Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppressionJ M Orenstein, N Bhat, C Yoder, et al.
Neuroscience|November 14, 2017
The Interval Between VNS-Tone Pairings Determines the Extent of Cortical Map PlasticityMichael S Borland, Crystal T Engineer, William A Vrana, et al.
Pharmacotherapy|December 28, 1999
Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction studyJ Falloon, S Sargent, S C Piscitelli, et al.
The New England Journal of Medicine|October 31, 1996
Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virusJ A Kovacs, S Vogel, J M Albert, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 27, 2015
Effects of sleeping with reduced carbohydrate availability on acute training responsesStephen C Lane, Donny M Camera, David Gray Lassiter, et al.
The Journal of Infectious Diseases|April 1, 1997
Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected personsR T Davey, D G Chaitt, S C Piscitelli, et al.
Transplantation Proceedings|December 1, 1996
Discovery of FK 506 analogues that are nontoxic to mouse pancreatic beta cells in vitro but show diabetogenic potential when administered to the ratK W Mollison, J M Andrews, T A Fey, et al.
Pageof 71

Showing results (621-630 of 703) with videos related to

Sort By:
Pageof 71
The Journal of Infectious Diseases|November 1, 1994
Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasmaR L Dewar, H C Highbarger, M D Sarmiento, et al.
The Journal of Infectious Diseases|March 14, 1998
Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoireJ C Gea-Banacloche, E E Weiskopf, C Hallahan, et al.
Science (New York, N.Y.)|September 7, 2019
Evaluation of an antibody to α<sub>4</sub>β<sub>7</sub> in the control of SIVmac239-<i>nef-stop</i> infectionM Di Mascio, J D Lifson, S Srinivasula, et al.
AIDS (London, England)|September 14, 2000
Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppressionJ M Orenstein, N Bhat, C Yoder, et al.
Neuroscience|November 14, 2017
The Interval Between VNS-Tone Pairings Determines the Extent of Cortical Map PlasticityMichael S Borland, Crystal T Engineer, William A Vrana, et al.
Pharmacotherapy|December 28, 1999
Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction studyJ Falloon, S Sargent, S C Piscitelli, et al.
The New England Journal of Medicine|October 31, 1996
Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virusJ A Kovacs, S Vogel, J M Albert, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 27, 2015
Effects of sleeping with reduced carbohydrate availability on acute training responsesStephen C Lane, Donny M Camera, David Gray Lassiter, et al.
The Journal of Infectious Diseases|April 1, 1997
Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected personsR T Davey, D G Chaitt, S C Piscitelli, et al.
Transplantation Proceedings|December 1, 1996
Discovery of FK 506 analogues that are nontoxic to mouse pancreatic beta cells in vitro but show diabetogenic potential when administered to the ratK W Mollison, J M Andrews, T A Fey, et al.
Pageof 71